Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2003
11/26/2003CN1457783A Sparxacin dripping pill for resisting bacterial infection and its preparing method
11/26/2003CN1457782A Dry spaxxacin suspension agent for resisting bacterial infection and its preparing method
11/26/2003CN1457781A Cetirizing hydrochloride cataplasm preparation
11/26/2003CN1457779A Medicinal composition for curing trachitis
11/26/2003CN1457776A Self emulsified soft capsule of ginkgo leaf extract and its preparing method
11/26/2003CN1457773A Biguanide vanadium complex granular powder and/or capsule for curing diabetes and its use
11/26/2003CN1457772A Injection for curing acute lung injury and acute respirotary distress syndrome
11/26/2003CN1457770A Anti-virus arosol inhalation medicine liquid
11/26/2003CN1457769A Self adhesive medical medicine plaster
11/26/2003CN1457768A Compound tablet capable of controlling release of effective component after oral administration
11/26/2003CN1457767A Method for preparing traditional Chinese medicine concentrated pill
11/26/2003CN1457766A Mucilage antiseptic medicine composition capable of being locally administratied and sustainably released and its preparing method
11/26/2003CN1457765A Cetirizine hydrochloride gel
11/26/2003CN1457688A Brain strengthening chewing tablet for child
11/26/2003CN1128885C Method for drying lactulose solution
11/26/2003CN1128704C Method for producing layered product
11/26/2003CN1128658C Method of mixing or dispersing liquid
11/26/2003CN1128636C Pharmaceutical angiostatic dipeptide compositions and method of use thereof
11/26/2003CN1128635C Amber anti-inflammatory pain-stopping powder medicine
11/26/2003CN1128633C Exterior-applied medicine for treating gynopathy
11/26/2003CN1128631C External-use medicinal plaster for curing bone disease
11/26/2003CN1128627C Plaster for treating rheumatism and its preparing method
11/26/2003CN1128619C Utilization of powder prepns. contg. hydroxypyridones treating leg ulcer and decubitus ulcers
11/26/2003CN1128618C Use of histamine for elevating blood histamine
11/26/2003CN1128615C Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
11/26/2003CN1128614C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and preparation containing it
11/26/2003CN1128612C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
11/25/2003US6653481 Used as calcium channel blockers
11/25/2003US6653427 Introducing monomeric 2-hydroxyethyl methacrylate containing ethylene glycol dimethacrylate impurities in the range of 0.05 to 0.1% by weight with hydroxybutyl acrylate into a solution of water and alcohol, copolymerizing; gel-free
11/25/2003US6653426 Polymer compositions for intraluminal stent
11/25/2003US6653352 Pain reliever and method of use
11/25/2003US6653339 Method of treating irritable bowel syndrome
11/25/2003US6653329 Granulated pharmaceutical formulations and methods for making the same
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653285 Polypeptide inhibitors and enhancers of glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparin, keratan sulfate, chitin and chitosans; antiinflammatory and anticarcinogenic agents; infections
11/25/2003US6653284 Keratinocyte growth factor-2 formulations
11/25/2003US6653281 Ring modified cyclic peptide analogs
11/25/2003US6652967 Nano-dispersed powders and methods for their manufacture
11/25/2003US6652903 Dry-copying method for producing flat, individually dosed preparations of active agents
11/25/2003US6652902 Water soluble polymers comprising phenylboronic acid crosslinked by mixing in water with polymers containing hydroxy/carboxy groups; useful in prevention of adhesions, as sealants, and for controlled drug delivery
11/25/2003US6652895 Carbohydrate matrix
11/25/2003US6652890 Treating cancer cells that express a membrane protein tNOX, a hormone-insensitive and drug-responsive form of NOX (NADH oxidase) specific to cancer cells
11/25/2003US6652886 Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
11/25/2003US6652885 Complexing drug with diketopiperazine; washing; separation of impurities
11/25/2003US6652884 Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel
11/25/2003US6652882 Containing uncrosslinked polymer, crosslinked insoluble polymer or mixture
11/25/2003US6652881 Micronized, quick dissolving; water, polysorbate 80 and sodium lauryl sulfate
11/25/2003US6652880 Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
11/25/2003US6652879 Improving the palatability of fish oil medicinals; gelatin, gelatin softener, water and water soluble flavoring agent
11/25/2003US6652877 With lipid or liposomal compounds
11/25/2003US6652876 Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics
11/25/2003US6652875 Casein formulations for the delivery of bioactive constituents
11/25/2003US6652874 Pharmaceutical preparations and methods for their regional administration
11/25/2003US6652873 Compositions and methods for enhancing receptor-mediated cellular internalization
11/25/2003US6652865 For decreasing the effect of intestinal metabolism on a drug
11/25/2003US6652850 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
11/25/2003US6652840 Aluminum chloride, ferric sulfate, regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and solvent; easy to use; reducing heart rate stimulation, staining, acid irritations and adhesive interference
11/25/2003US6652839 Chewing gum with liquid medium
11/25/2003US6652838 Method for treating diabetes mellitus
11/25/2003US6652837 Preparation of novel particles for inhalation
11/25/2003US6652575 Stent with smooth ends
11/25/2003US6652510 Implantable infusion device and reservoir for same
11/25/2003CA2268887C Closure system for an active agent delivery device
11/25/2003CA2258811C Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/25/2003CA2119145C Ferrite particles and therapeutic and diagnostic uses therefore
11/21/2003CA2385529A1 Stable dosage forms comprising atorvastatin calcium
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095641A1 Intracellular protein delivery compositions and methods of use
11/20/2003WO2003095569A1 Capsules printed with sepia colored containing inks
11/20/2003WO2003095548A1 Modified polymeric films
11/20/2003WO2003095498A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003WO2003095479A1 Multiple branch peptide constructions comprising from 2 to 16 branches of the peptide rqgys or from 8 to 16 branches of the peptide rqgy providing from the hiv gp41 glycoprotein
11/20/2003WO2003095464A1 Phosphatidyl oligo glycerins and structural analogs
11/20/2003WO2003095085A1 Colloidal dispersion of calcium phosphate nanoparticles and at least one protein, and corresponding redispersible and calcined nanoparticles, preparation method and uses
11/20/2003WO2003095029A1 Bisphosphonic acid for the treatment and prevention of osteoporosis
11/20/2003WO2003095012A1 Method and apparatus for vaporizing a compound
11/20/2003WO2003095011A1 Medicament respiratory delivery device and cartridge
11/20/2003WO2003094976A1 Lyophilized edible food incorporating a marker
11/20/2003WO2003094971A1 Cationic lipids for intracellular delivery of bioactive substances
11/20/2003WO2003094951A1 Soluble formulations comprising insulin aspart and insulin detemir
11/20/2003WO2003094942A1 Soluble composition containing sporopollenin and the use thereof
11/20/2003WO2003094941A1 Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof
11/20/2003WO2003094940A1 Medicament for prevention and treatment of fracture and osteoporosis
11/20/2003WO2003094930A1 Embolization using degradable crosslinked hydrogels
11/20/2003WO2003094925A1 Injectable bisphosphonate formulations
11/20/2003WO2003094920A1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
11/20/2003WO2003094911A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
11/20/2003WO2003094909A2 Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease
11/20/2003WO2003094906A1 Anti-rhinovirus active agents
11/20/2003WO2003094905A1 Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
11/20/2003WO2003094900A1 Delivery of drug amines through an inhalation route
11/20/2003WO2003094899A1 Novel method of preparing programmed-release compositions containing (s)-1-[n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline and the product thus obtained
11/20/2003WO2003094898A2 Microcapsules containing biomedical materials
11/20/2003WO2003094897A1 Photostabilized soft capsule
11/20/2003WO2003094896A1 A method to improve surface properties of pharmaceutical tablets
11/20/2003WO2003094895A1 Extended release tablets comprising felodipine
11/20/2003WO2003094894A1 Nanoparticulate nystatin formulations
11/20/2003WO2003094893A1 Process for preparing an injection type solid chitosan powder
11/20/2003WO2003094892A1 Conversion of amorphous material to a corresponding crystalline material by spray drying and utilization of the crystalline spray dried material in drug formulations
11/20/2003WO2003094891A1 Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs